The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Biogen’s big reveal, hot takes on Alzheimer’s, & the science of one-eyed sheep
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Warren’s awkward home front, the ethics of treating dwarfism, and the sound of STAT Summit
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Google’s data grab, problematic genetic testing, & the perils of biotech Twitter
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: An uncertain Alzheimer’s idea, blockbuster fish oil, & a little self-indulgence
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Drugs that don’t work, wearables in the desert, & excess ‘innovation’
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Every angle on Biogen’s shocking Alzheimer’s news
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Pharma’s future in China, CRISPR meets Netflix, & where VC dollars come from
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Relitigating Vioxx, industry growing pains, & how biotech VC works
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Congressional paralysis, drug shortages, & biotech’s foul mood
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Vaping upheaval, DNA test dynamics, & the future of genome editing
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Unicorn growth spurts, Amgen’s future, & mice on Twitter
The Readout LOUD By Adam Feuerstein and Rebecca Robbins Listen: Pelosi’s drug pricing plan, Moderna’s mRNA drug factories, and a DIY disease cure
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Pharma existentialism, mainstreaming cyborgs, & FDA palace intrigue
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Purdue, J&J, and a week of big opioid crisis news
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Sarepta keeps a secret, an online army mobilizes, & China embraces biotech
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: The serious side of spit kits, how BiTEs leave a mark, & Sarepta’s sluggish study
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Novartis and the no good, very bad week
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Canadian pills, corporate jets, & racists with spit kits
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Vertex’s regime change, the return of Ebola, & the rise of digital health
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Elon Musk’s monkey cyborg, Gilead’s shifting future, & an app for anxiety
The Readout LOUD By Damian Garde and Rebecca Robbins Listen: A whirlwind week in Washington, Sean Parker’s mansion, & remembering a resonant voice in biotech
The Readout LOUD By Damian Garde and Adam Feuerstein Listen: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: A controversial desire drug, courtroom genealogy, & the quest for longer life
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Biohacking meets bureaucracy, and the latest twist in CRISPR world
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party
The Readout LOUD By Adam Feuerstein and Matthew Herper Listen: A special episode from the halls of the ASCO meeting
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Feuding professors, failing businesses, and journalism 101
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Your ASCO preview, genetic whiplash, and a journalist’s experience with cancer
The Readout LOUD By Damian Garde and Rebecca Robbins Listen: Drug pricing partisanship, tech’s march into health care, and Tinder for clinical trials
